Addition of intravenous N-methyl-D-aspartate receptor antagonists to local fibrinolytic therapy for the optimal treatment of experimental intracerebral hemorrhages

Journal of Neurosurgery

Volumn 106, Issue 2, 2007, Pages 314-320

  Thiex, Ruth ^a   Weis, Joachim ^a   Krings, Timo ^a   Barreiro, Sonia ^a   Yakisikli Alemi, Funda ^a   Gilsbach, Joachim M ^a   Rohde, Veit ^a,b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Brain edema; Fibrinolysis; Intracerebral hemorrhage; N methyl D aspartate receptor antagonist

Indexed keywords

ALTEPLASE; DIZOCILPINE; FIBRINOLYTIC AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; ENCEPHALITIS; FIBRINOLYTIC THERAPY; HISTOPATHOLOGY; MALE; MONOTHERAPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SWINE; VOLUMETRY;

ANIMALS; BRAIN EDEMA; CEREBRAL HEMORRHAGE; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FIBRINOLYTIC AGENTS; INFUSIONS, INTRAVENOUS; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; SWINE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33846847712     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2007.106.2.314     Document Type: Article

References (40)

1. Backlund EO, van Holst M: Controlled subtotal evacuation of intracerebral haematomas by stereotactic technique. Surg Neurol 9:99-101, 1978
2. Brunello AG, Weissenberger J, Kappeler A, Vallan C, Peters M, Rose-John S, et al: Astrocytic alterations in interleukin-6/soluble interleukin-6 receptor alpha double-transgenic mice. Am J Pathol 157:1485-1493, 2000
3. Buchan AM, Slivka A, Xue D: The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 574:171-177, 1992
4. Buchan AM, Warren DT: tPA toxicity in experimental cerebral ischemia: mechanisms and clinical implications, in Krieglstein J, Klumpp S (eds): Pharmacology of Cerebral Ischemia. Amsterdam: Elsevier, 2002, pp 191-199
5. Bugge TH, Flick MJ, Daugherty CC, Degen JL: Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 9:794-807, 1995
6. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, et al: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424, 1994
7. Doi E, Moriwaki M, Komai N, Iwamoto M: [Stereotactic evacuation of intracerebral hematomas.] Neurol Med Chir (Tokyo) 22:461-467, 1982 (Jpn)
8. Flavin MP, Zhao G, Ho LT: Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 29:347-354, 2000
9. Higgins AC, Nashold BS Jr: Stereotactic evacuation of large intracerebral hematoma. Appl Neurophysiol 43:96-103, 1980
10. Hirate K, Kitayama A, Furuya N: Roles of glutamate receptor subtypes in the development of vestibular compensation after unilateral labyrinthectomy in guinea pigs. Neurosci Lett 296:158-162, 2000
11. Ichord RN, Johnston MV, Traystman RJ: MK801 decreases glutamate release and oxidative metabolism during hypoglycemic coma in piglets. Brain Res Dev Brain Res 128:139-148, 2001
12. Kilic E, Bahr M, Hermann DM: Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice: role of hemodynamic alterations. Stroke 32:2641-2647, 2001
13. Kochhar A, Zivin JA, Lyden PD, Mazzarella V: Glutamate antagonist therapy reduces neurological deficits produced by focal central nervous system ischemia. Arch Neurol 45:148-153, 1988
14. Küker W, Thiex R, Rohde I, Rohde V, Thron A: Experimental acute intracerebral hemorrhage. Value of MR sequences for a safe diagnosis at 1.5 and 0.5 T. Acta Radiol 41:544-552, 2000
15. Lippitz BE, Mayfrank L, Spetzger U, Warnke JP, Bertalanffy H, Gilsbach JM: Lysis of basal ganglia haematoma with recombinant tissue plasminogen activator (rtPA) after stereotactic aspiration: initial results. Acta Neurochir (Wien) 127:157-160, 1994
16. Lo EH, Broderick JP, Moskowitz MA: tPA and proteolysis in the neurovascular unit. Stroke 35:354-356, 2004
17. Lo EH, Wang X, Cuzner ML: Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res 69:1-9, 2002
18. Matsumoto K, Hondo H: CT-guided stereotaxic evacuation of hypertensive intracerebral hematomas. J Neurosurg 61:440-448, 1984
19. Matys T, Strickland S: Tissue plasminogen activator and NMDA receptor cleavage. Nature Med 9:371-373, 2003
20. Mohadjer M, Braus DF, Myers A, Scheremet R, Krauss JK: CT-stereotactic fibrinolysis of spontaneous intracerebral hematomas. Neurosurg Rev 15:105-110, 1992
21. Nagai N, De Mol M, Lijnen HR, Carmeliet P, Collen D: Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 99:2440-2444, 1999
22. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, et al: The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nature Med 7:59-64, 2001
23. Ozyurt E, Graham DI, Woodruff GN, McCulloch J: Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat. J Cereb Blood Flow Metab 8:138-143, 1988
24. Rohde V, Rohde I, Reinges MH, Mayfrank L, Gilsbach JM: Frameless stereotactically guided catheter placement and fibrinolytic therapy for spontaneous intracerebral hematomas: technical aspects and initial clinical results. Minim Invasive Neurosurg 43:9-17, 2000
25. Rohde V, Rohde I, Thiex R, Ince A, Jung A, Dückers G, Gröschel K, et al: Fibrinolyis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97:954-962, 2002
26. Rosenberg GA, Navratil M: Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48:921-926, 1997
27. Schaller C, Rohde V, Meyer B, Hassler W: Stereotactic puncture and lysis of spontaneous intracerebral hemorrhage using recombinant tissue-plasminogen activator. Neurosurgery 36:328-335, 1995
28. Sereghy T, Overgaard K, Boysen G: Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats. Stroke 24:1702-1708, 1993
29. Steinberg GK, Saleh J, Kunis D, DeLaPaz R, Zarnegar SR: Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits. Stroke 20:1247-1252, 1989
30. Thiex R, Küker W, Müller HD, Rohde I, Schröder JM, Gilsbach JM, et al: The long-term effect of recombinant tissue-plasminogen- activator (rt-PA) on edema formation in a large-animal model of intracerebral hemorrhage. Neurol Res 25:254-262, 2003
31. Thiex R, Mayfrank L, Rohde V, Gilsbach JM, Tsirka SA: The role of endogenous versus exogenous tPA on edema formation in murine ICH. Exp Neurol 189:25-32, 2004
32. Thiex R, Rohde V, Rohde I, Mayfrank L, Zeki Z, Thron A, et al: Frame-based and frameless stereotactic hematoma puncture and subsequent fibrinolytic therapy for the treatment of spontaneous intracerebral hemorrhage. J Neurol 251:1443-1450, 2004
33. Tsirka SE: Clinical implications of the involvement of tPA in neuronal cell death. J Mol Med 75:341-347, 1997
34. Tsirka SE, Gualandris A, Amaral DG, Strickland S: Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340-344, 1995
35. Tsirka SE, Rogove AD, Strickland S: Neuronal cell death and tPA. Nature 384:123-124, 1996
36. Wang X, Asahi M, Lo EH: Tissue type plasminogen activator amplifies hemoglobin-induced neurotoxicity in rat neuronal cultures. Neurosci Lett 274:79-82, 1999
37. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA: Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228-231, 1998
38. Warren DT, Klein G, Eliasziw M, Buchan AM: Neurotoxic effects of t-PA in a rat model of permanent focal ischemia. Neurology 60 (1 Suppl):A65, 2003 (Abstract)
39. Williams JA, Colon RJ, Weiss HR: Effect of N-methyl-D-aspartate receptor blockade on the control of cerebral O2 supply/consumption balance during hypoxia in newborn pigs. Neurochem Res 23:1139-1145, 1998
40. Zimmerman RA: Recent advances in MR imaging: FLAIR imaging. Crit Rev Neurosurg 8:188-192, 1998